Observational Study on GEP-and Pulm-NET Treated at FPG

Abroad (travel likely)Recruiting

Conditions

Neuroendocrine Tumors · Gep Net · Pulmonary Neuroendocrine Neoplasm

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy
Contact: Study coordinator (Maria Grazia Maratta) · mariagrazia.maratta@guest.policlinicogemelli.it
Contact: Study coordinator (Giovanni Schinzari) · giovanni.schinzari@policlinicogemelli.it

Study leads

Giovanni Schinzari
Principal Investigator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Gastroenteropancreatico Tumors · Neuroendocrine Tumors · Neuroendocrine Neoplasms

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

Malignant Brain Neoplasm · Malignant Solid Neoplasm · Multiple Sclerosis

Abroad (travel likely)Recruiting

Rochester, United States

DCEUS to Assess Treatment Response to PRRT in GEP-NET

NET · Radionucleide Therapy · Contrast Enhanced Ultrasound

Abroad (travel likely)Recruiting

Rome, Italy

PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours

Neuroendocrine Tumors

Abroad (travel likely)RecruitingPHASE1

Melbourne, Australia